As biotech markets begin to show signs of life, how should company leaders and investors prepare for what’s next?
Biotech executives, investment bankers and partners from Deloitte’s life sciences practice and Fenwick’s...more
Throughout the last few years, investors, proxy advisors, governance professionals and a number of stakeholders have expressed a keen interest in how companies are managing their environmental, social and governance (ESG)...more
3/7/2022
/ Capital Markets ,
Corporate Counsel ,
Corporate Governance ,
Environmental Social & Governance (ESG) ,
Investors ,
Proxy Advisors ,
Public Disclosure ,
Publicly-Traded Companies ,
Regulatory Oversight ,
Reporting Requirements ,
Shareholders ,
Silicon Valley ,
Technology Sector
In the last few years, environmental, social and governance (ESG) topics have become common in boardrooms, as investment funds with an ESG focus have raised billions and ESG’s non-financial metrics are increasingly factored...more